Prof. dr hab. n. med. Dariusz Pytel

Prof. dr hab. n. med. Dariusz Pytel

Kierownik/główny wykonawca projektów badawczych, w tym: NCN (Narodowe Centrum Nauki), NRSA (National Research Service Award, USA) NIH (National Institutes of Health, USA), NCI (National Cancer Institute, USA).

Prof. dr hab. n. med. Dariusz Pytel

Katedra Chemii i Biochemii Medycznej Uniwersytetu Medycznego w Łodzi

Doświadczenie zawodowe: 2005 – 2008 – Research Scholar Temple University School of Medicine Department of Microbiology and Immunology; 2009 – 2010 – Visiting Postdoctoral Fellow Laboratory for Drug Discovery in Neurodegeneration (LDDN) Harvard NeuroDiscovery Center, Brigham and Women’s Hospital, Harvard Medical School; 2008 – 2013 – Postdoctoral Fellow Abramson Family Cancer Research Institute Perelman School of Medicine at the University of Pennsylvania, Department of Cancer Biology; 2013 – 2014 Research Assistant Professor Abramson Family Cancer Research Institute Perelman School of Medicine at the University of Pennsylvania, Department of Cancer Biology; 2014 – 2020 – Research Assistant Professor Department of Biochemistry and Molecular Biology, Medical University of South Carolina.

Kierownik/główny wykonawca projektów badawczych, w tym: NCN (Narodowe Centrum Nauki), NRSA (National Research Service Award, USA) NIH (National Institutes of Health, USA), NCI (National Cancer Institute, USA).

Członek panelu recenzentów czasopism naukowych: DNA and Cell Biology, Acta Ophthalmologica, Folia Histochemica et Cytobiologica, Molecular Biology Reports.

Współpraca naukowa: Glaxo Smith Kline (GSK); Eli Lilly and Company,; Atomwise, Inc., University of Florida; Harvard Medical School; Perelman School of Medicine at the University of Pennsylvania; Wistar Institute; Medical University of South Carolina, Case Western Reserve University.

„Naukowcy przyszłości”: Life science – Od podstaw do innowacji